About this trial
Brief Summary:
This single-blind, randomized controlled trial will investigate the efficacy of bee venom phonophoresis in managing pain and improving mobility in patients with knee osteoarthritis. Thirty adults aged 40-75 years with clinically and radiographically confirmed knee osteoarthritis will be randomly assigned to receive either bee venom phonophoresis or placebo phonophoresis with a neutral gel. Ultrasound parameters will be standardized for all participants.
Primary outcomes are pain reduction, measured by the Visual Analog Scale (VAS), and functional mobility, assessed by the Timed Up and Go (TUG) test. The secondary outcome is walking endurance, measured by the Six-Minute Walk Test (6MWT). Assessments will be conducted at baseline and post-intervention.
The study is designed to determine whether bee venom phonophoresis offers greater clinical benefit compared to placebo phonophoresis, potentially providing a non-invasive, adjunctive treatment option for knee osteoarthritis. Ethical approval has been obtained from the Faculty of Physical Therapy, Sinai University, and all participants will provide written informed consent.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 40-75 years
Clinically and radiographically confirmed knee osteoarthritis
Moderate to severe pain (VAS ≥ 4)
Willingness to provide informed consent
Disqualifiers
Allergy to bee products or topical agents used in the study
Knee surgery or trauma in the past year
Intra-articular injection in the past 6 months
Other musculoskeletal or systemic conditions affecting the knees (e.g., rheumatoid arthritis)
Trial design
Parallel
Treatments tested in this trial
Ultrasound therapy unit
DeviceUltrasound therapy unit
Bee venom topical preparation (for phonophoresis)
Biological/VaccineBee venom topical preparation (for phonophoresis)
Treatment groups
Trial outcomes
Primary outcomes
Change in Pain Intensity
Measured using the Visual Analog Scale (VAS), a 10-cm scale ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain severity.
Change in Functional Mobility
Measured using the Timed Up and Go (TUG) test, which records the time (in seconds) taken for a participant to stand up from a chair, walk 3 meters, turn, return, and sit down. Lower times indicate better mobility.
Secondary outcomes
Change in Walking Endurance
Measured using the Six-Minute Walk Test (6MWT), recording the total distance (in meters) walked in six minutes on a flat surface. Greater distances indicate improved endurance.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: